Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

general

An aggressive primary cutaneous B-cell lymphoma, usually involving the lower leg. It is composed of a generally monotonous proliferation of immunoblasts, or less frequently centroblasts, with few admixed reactive cells. This type of lymphoma occurs most often in elderly women who present with rapidly growing tumors, usually on one or both legs. Dissemination to extracutaneous sites is frequent. Treatment with combination chemotherapy is usually required.

Centers

Active Trials

$1.6B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	15	16
Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	15	16

Top Centers for Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	51.7
2	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	51.7
3	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive	2	—	51.7
4	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive	—	—	51.7
5	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive	—	—	51.7
6	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	2	—	51.7
7	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive	2	—	51.7
8	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	51.7
9	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	2	—	51.7
10	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	51.7
11	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	51.7
12	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	51.7
13	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	2	—	51.7
14	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	51.7
15	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	51.7
16	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	2	—	51.7
17	Cedars-Sinai CancerLos Angeles, CA	—	—	51.7
18	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive	—	—	51.7
19	Cleveland Clinic Cancer CenterCleveland, OH	—	—	51.7
20	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	51.7
21	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive	—	—	51.7
22	University of Illinois Cancer CenterChicago, IL	2	—	51.7
23	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	—	51.7
24	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	51.7
25	Boston University Cancer CenterBoston, MA	—	—	51.7
26	Cancer Center at IllinoisUrbana, IL	2	—	51.7
27	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	—	51.7
28	Upstate Cancer CenterSyracuse, NY	—	—	51.7
29	Louisiana Cancer Research CenterNew Orleans, LA	—	—	51.7
30	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	2	$534M	—
31	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive	2	$438M	—
32	Moffitt Cancer CenterTampa, FL NCI Comprehensive	2	$296M	—
33	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	2	$134M	—
34	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive	2	$130M	—
35	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL	4	$59M	—
36	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	2	$58M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →